Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

From Birth to Midlife-Liver Function, Fibrosis and Mortality in Individuals with Severe Alpha-1-Antitrypsin Deficiency Identified by Neonatal Screening.

Journal of clinical medicine·2026

Same author

Severe α<sub>1</sub>-Antitrypsin Deficiency and Increased Risk of Gastrointestinal Diseases.

Mayo Clinic proceedings·2026

Same author

COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden.

Scientific reports·2026

Same author

Predictive value of aorta enhancement on computed tomographic pulmonary angiography in pulmonary embolism.

PloS one·2025

Same author

Automatic joint inflammation estimation based on regression neural networks.

Medical physics·2025

Same author

Signs of Hyperinflation and Ventilation Heterogeneity in Individuals With Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.

International journal of chronic obstructive pulmonary disease·2025

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

Progression parameters for emphysema: a clinical investigation.

Jan Stolk¹, Hein Putter, Els M Bakker

¹Department of Pulmonology, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. j.stolk.long@lumc.nl

Respiratory Medicine

|July 24, 2007

Summary

Lung densitometry using CT scans detects emphysema progression 2.5 times more sensitively than standard lung function tests. This finding supports CT scans for evaluating new emphysema treatments.

More Related Videos

Measurement of the Pressure-volume Curve in Mouse Lungs

Measurement of the Pressure-volume Curve in Mouse Lungs

Published on: January 27, 2015

Related Experiment Videos

Last Updated: Jul 13, 2026

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

Measurement of the Pressure-volume Curve in Mouse Lungs

Measurement of the Pressure-volume Curve in Mouse Lungs

Published on: January 27, 2015

Area of Science:

Pulmonology
Radiology
Medical Imaging

Background:

Emphysema progression is difficult to track using current lung function tests.
Computed tomography (CT)-derived lung density correlates with emphysema pathology.
The sensitivity of lung densitometry for detecting emphysema progression is debated.

Purpose of the Study:

To compare the sensitivity of lung densitometry versus spirometry and gas transfer for detecting emphysema progression.
To evaluate CT-derived lung density as a marker for disease progression in chronic obstructive pulmonary disease (COPD).

Main Methods:

144 COPD patients underwent CT scans, spirometry, and carbon monoxide diffusion tests at baseline and after 30 months.
Quantitative CT-derived lung density and standard lung function parameters were measured.
Signal-to-noise ratio was calculated to assess the sensitivity of each parameter for detecting annual change.

Main Results:

Lung densitometry showed a significant annual decrease (p=0.0015), unlike FEV(1) and gas transfer (p=0.2).
The signal-to-noise ratio for detecting annual change was 3.2 for lung densitometry, compared to 1.3 for FEV(1) and gas diffusion.
Lung densitometry demonstrated 2.5-fold greater sensitivity in detecting emphysema progression.

Conclusions:

Lung densitometry is a more sensitive method for tracking emphysema progression in COPD patients.
CT scans may be an effective tool for assessing novel emphysema therapies.
This study supports the use of quantitative CT analysis in COPD research and clinical trials.